MiRNAs are involved in many aspects of Alzheimer’s disease progression including direct regulation of APP expression [92], alternative splicing of APP [93], regulation of BACE [94,95,96], regulation of Tau [97] and even lipid metabolism [98]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.